"The simplest view appears to me undoubtedly to be that in an early stage of embryonic development more cells are produced than are required for building up the part concerned, so that there remains unappropriated a quantity of cells-it may be very few in number-which, owing to their embryonic character, are endowed with a marked capacity for proliferation... The only point on which I lay stress is that the real cause of the subsequent tumour is to be sought in a fault or irregularity Recent results have supported the cancer stem cells hypothesis in which tumors originate from tissue stem cells or their early progenitors and, as a result, produce tumors that retain stem cell properties. These properties include selfrenewal that drives tumorigenesis and differentiation that contributes to cellular heterogeneity. The number of these cells is very small, and is tightly controlled by the self-renewal pathway and the signals of their environment (niche). Evidence for the existence of cancer stem cells has been reported for a number of human cancers including leukemia, cancers of the breast, brain, and colon. Although our understanding of the biology of these cancer stem cells remains rudimentary, the existence of these cells has implications for current conceptualization of malignant transformation and targeted therapy for the treatment of cancer.
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